ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2026
Cost-effectiveness of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists for patients with high cardiovascular risk and type 2 diabetes in Canada.
Ethan S McNally et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.